APP and Alzheimer disease: Amyloid-beta (Aβ) is known to play a key role in AD pathogenesis, which is confirmed by familial mutations of amyloid precursor protein (APP) and presenilin and defines the disease and vaccines against Aβ have shown therapeutic promise [5].